Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study
This study is not yet open for participant recruitment.
Verified October 2011 by Shanghai Zhongshan Hospital
Sponsor:
Meng Su Zeng
Collaborators:
Changhai Hospital
Shanghai Cancer Hospital, China
Ruijin Hospital
Huashan Hospital
Fudan University
Information provided by (Responsible Party):
Meng Su Zeng, Shanghai Zhongshan Hospital
ClinicalTrials.gov Identifier:
NCT01455610
First received: October 18, 2011
Last updated: October 19, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this multicenter and double-blind clinical trial is to prospectively assess the sensitivity, specificity, negative predictive value, positive predictive value, and accuracy in respectability of pancreatic head cancer with contrasted-enhanced MDCT and its various post processing techniques, taking operational and pathological records as the gold standard.
| Condition |
|---|
|
Adenocarcinoma of Head of Pancreas |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Preoperative Evaluation of Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study |
Resource links provided by NLM:
Further study details as provided by Shanghai Zhongshan Hospital:
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Out-patients or in-patients,with(or suspected) pancreatic head cancer, both have MDCT examinaton and receive surgery treatment
Criteria
Inclusion Criteria:
- Patients with (or suspected) pancreatic head cancer
- Being examined by contrasted-enhanced MDCT
- Receiving surgical treatment (including palliative surgery) in all research centers
Exclusion Criteria:
- Patients having (or suspected) pregnancy or breast-feeding
- Patients having allergic reactions to iodinated contrast agents or Hypersensitivity reactions to allergens(including drugs)
- Patients receiving ERCP before contrasted-enhanced MDCT examination
- Patients without surgery because of a high degree of surgical risk
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01455610
Contacts
| Contact: Mengsu Zeng, MD, PhD | +86-021-64041990-2130 | zengmengsu@gmail.com |
| Contact: Xiuzhong Yao, MD, PhD | +86-021-64041990-5425 | fjqzyaoxz02@163.com |
Locations
| China, Shanghai | |
| Radiology Department, Zhongshan Hospital, Fudan University | Not yet recruiting |
| Shanghai, Shanghai, China, 200032 | |
| Contact: Mengsu Zeng, MD, PhD +86-021-64041990-2130 zengmengsu@gmail.com | |
| Principal Investigator: Mengsu Zeng, MD, PhD | |
| Radiology Department, Changhai Hospital Affiliated to the Second Military Medical University | Not yet recruiting |
| Shanghai, Shanghai, China, 200433 | |
| Contact: Jianping Lu, MD, PhD +86-13701775219 13701775219@163.com | |
| Principal Investigator: Jianping Lu, MD, Phd | |
| Radiology Department, Cancer Hospital, Fuandan University | Not yet recruiting |
| Shanghai, Shanghai, China, 200032 | |
| Contact: Weijun Peng, Md, PhD +86-13564682870 Huizhu171717@163.com | |
| Principal Investigator: Weijun Peng, MD, PhD | |
| Radiology Department, Ruijing Hospital, Shanghai Jiaotong University | Not yet recruiting |
| Shanghai, Shanghai, China, 200025 | |
| Contact: Fuhua Yan, MD, PhD +86-13764236797 Lin-xiaozhu-rj@hotmail.com | |
| Principal Investigator: Fuhua Yan, MD, PhD | |
| Radiology Department, Huashan Hospital, Fudan University | Not yet recruiting |
| Shanghai, Shanghai, China, 200040 | |
| Contact: Xiaoyuan Feng, MD, PhD +86-13601659304 liangzh@vip.163.com | |
| Principal Investigator: Xiaoyuan Feng, MD, PhD | |
| Radiology Department, Huadong Hospital, Fudan University | Not yet recruiting |
| Shanghai, Shanghai, China, 200040 | |
| Contact: Yanqing Hua, MD, PhD +86-13774234090 13774234090@163.com | |
| Principal Investigator: Yanqing Hua, MD, PhD | |
Sponsors and Collaborators
Meng Su Zeng
Changhai Hospital
Shanghai Cancer Hospital, China
Ruijin Hospital
Huashan Hospital
Fudan University
Investigators
| Study Chair: | Mengsu Zeng, MD, PhD | Radiology Department, Zhongshan Hospital of Fudan University |
| Principal Investigator: | Jianping Lu, MD,PhD | Radiology Department, Changhai Hospital Affiliated to Second Military Medical University |
| Principal Investigator: | Weijun Peng, MD, PhD | Radiology Department, Cancer Hospital Affiliated to Fudan University |
| Principal Investigator: | Fuhua Yan, MD, PhD | Radiology Department, Ruijin Hospital Affiliated to Shanghai Jiaotong University, China |
| Principal Investigator: | Xiaoyuan Feng, MD, PhD | Radiology Department, Huashan Hospital, Fudan University, China |
| Principal Investigator: | Yanqing Hua, MD, PhD | Radiology Department, Huadong Hospital Affiliated to Fudan University, China |
More Information
No publications provided
| Responsible Party: | Meng Su Zeng, Mengsu Zeng, MD & Ph.D,Chairman & Professor,Department of Radiology, Shanghai Zhongshan Hospital |
| ClinicalTrials.gov Identifier: | NCT01455610 History of Changes |
| Other Study ID Numbers: | ZMS-001 |
| Study First Received: | October 18, 2011 |
| Last Updated: | October 19, 2011 |
| Health Authority: | United States: Institutional Review Board China: Ethics Committee |
Keywords provided by Shanghai Zhongshan Hospital:
|
Computed tomography Contrast enhancement Pancreas Cancer Resectability |
Additional relevant MeSH terms:
|
Adenocarcinoma Adenocarcinoma, Mucinous Head and Neck Neoplasms Carcinoma Neoplasms, Glandular and Epithelial |
Neoplasms by Histologic Type Neoplasms Neoplasms, Cystic, Mucinous, and Serous Neoplasms by Site |
ClinicalTrials.gov processed this record on May 23, 2013